Essential Factors for Incompatible DNA End Joining at Chromosomal DNA Double Strand Breaks In Vivo

Non-homologous end joining (NHEJ) is a major pathway for the repair of DNA double strand break (DSBs) with incompatible DNA ends, which are often generated by ionizing irradiation. In vitro reconstitution studies have indicated that NHEJ of incompatible DNA ends requires not only the core steps of synapsis and ligation, employing KU80/DNA-PKcs and LIG4, but also additional DNA end processing steps, such as DNA end resection by Artemis and gap-filling by POLλ and POLμ. It seems that DNA end processing steps are important for joining of incompatible DNA ends rather than compatible ends. Despite the fact that DNA end processing is important for incompatible DNA end joining in vitro, the role of DNA processing in NHEJ of incompatible DSBs in vivo has not yet been demonstrated. Here we investigated the in vivo roles of proteins implicated in each step of NHEJ using an assay in which NHEJ of incompatible DNA ends on chromosomal DNA can be assessed in living human cells. siRNA- or inhibitor-mediated impairment of factors in each NHEJ step resulted in a reduction in joining efficiency. Strikingly, stronger effects were observed when DNA end resection and ligation protein functions were impaired. Disruption of synapsis by KU80 and DNA-PKcs impairment, or the disruption of gap filling by POLλ and POLμ depletion, resulted in higher levels of microhomology-mediated joining. The present study indicates that DNA end resection and ligation factors are critical for the efficient joining of incompatible ends in vivo, further emphasizing the importance of synapsis and gap-filling factors in preventing illegitimate joining.

[1]  A. Chinnaiyan,et al.  Triggers for genomic rearrangements: insights into genomic, cellular and environmental influences , 2010, Nature Reviews Genetics.

[2]  M. Lieber,et al.  Impact of DNA ligase IV on the fidelity of end joining in human cells. , 2003, Nucleic acids research.

[3]  T. Ørntoft,et al.  DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis , 2005, Nature.

[4]  David J. Chen,et al.  Role of non-homologous end joining (NHEJ) in maintaining genomic integrity. , 2006, DNA repair.

[5]  D. Ramsden,et al.  End-bridging is required for pol μ to efficiently promote repair of noncomplementary ends by nonhomologous end joining , 2008, Nucleic acids research.

[6]  Z. Herceg,et al.  Histone acetylation by Trrap–Tip60 modulates loading of repair proteins and repair of DNA double-strand breaks , 2006, Nature Cell Biology.

[7]  Dimitris Kletsas,et al.  Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions , 2005, Nature.

[8]  M. Lieber,et al.  The Mechanism of Human Nonhomologous DNA End Joining* , 2008, Journal of Biological Chemistry.

[9]  M. Lieber,et al.  The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway. , 2010, Annual review of biochemistry.

[10]  T. E. Wilson,et al.  DNA Joint Dependence of Pol X Family Polymerase Action in Nonhomologous End Joining* , 2005, Journal of Biological Chemistry.

[11]  H. Thierens,et al.  Lentivirus-mediated RNA interference of Ku70 to enhance radiosensitivity of human mammary epithelial cells , 2010, International journal of radiation biology.

[12]  Yunmei Ma,et al.  The DNA-dependent Protein Kinase Catalytic Subunit Phosphorylation Sites in Human Artemis* , 2005, Journal of Biological Chemistry.

[13]  Z. Livneh,et al.  Lesion Bypass by Human DNA Polymerase μ Reveals a Template-dependent, Sequence-independent Nucleotidyl Transferase Activity* , 2004, Journal of Biological Chemistry.

[14]  D. V. van Gent,et al.  The mechanism of non-homologous end-joining: a synopsis of synapsis. , 2004, DNA repair.

[15]  Yunmei Ma,et al.  A biochemically defined system for mammalian nonhomologous DNA end joining. , 2004, Molecular cell.

[16]  D. Weinstock,et al.  A model of oncogenic rearrangements: differences between chromosomal translocation mechanisms and simple double-strand break repair. , 2006, Blood.

[17]  D. Ramsden,et al.  Association of DNA Polymerase μ (pol μ) with Ku and Ligase IV: Role for pol μ in End-Joining Double-Strand Break Repair , 2002, Molecular and Cellular Biology.

[18]  K. Valerie,et al.  Regulation and mechanisms of mammalian double-strand break repair , 2003, Oncogene.

[19]  N. Curtin,et al.  Identification and Characterization of a Novel and Specific Inhibitor of the Ataxia-Telangiectasia Mutated Kinase ATM , 2004, Cancer Research.

[20]  S. Jackson,et al.  DNA-dependent protein kinase. , 1997, The international journal of biochemistry & cell biology.

[21]  G. Peng,et al.  BRIT1/MCPH1 Links Chromatin Remodeling to DNA Damage Response , 2009, Nature Cell Biology.

[22]  J. Hoeijmakers,et al.  Different types of V(D)J recombination and end‐joining defects in DNA double‐strand break repair mutant mammalian cells , 2002, European journal of immunology.

[23]  M. van der Burg,et al.  Non-homologous end-joining, a sticky affair. , 2007, Oncogene.

[24]  S. Jackson,et al.  Human HDAC1 and HDAC2 function in the DNA-damage response to promote DNA nonhomologous end-joining , 2010, Nature Structural &Molecular Biology.

[25]  Thomas Helleday,et al.  DNA repair pathways as targets for cancer therapy , 2008, Nature Reviews Cancer.

[26]  J. Yokota,et al.  Histone acetylation by CBP and p300 at double-strand break sites facilitates SWI/SNF chromatin remodeling and the recruitment of non-homologous end joining factors. , 2011, Oncogene.

[27]  Satoshi Nakajima,et al.  The ACF1 complex is required for DNA double-strand break repair in human cells. , 2010, Molecular cell.

[28]  J. Yokota,et al.  Involvement of Ku80 in microhomology-mediated end joining for DNA double-strand breaks in vivo. , 2007, DNA repair.

[29]  C. Desmaze,et al.  Impact of the KU80 pathway on NHEJ-induced genome rearrangements in mammalian cells. , 2004, Molecular cell.

[30]  Yunmei Ma,et al.  Hairpin Opening and Overhang Processing by an Artemis/DNA-Dependent Protein Kinase Complex in Nonhomologous End Joining and V(D)J Recombination , 2002, Cell.

[31]  N. Curtin,et al.  Radiosensitization and DNA repair inhibition by the combined use of novel inhibitors of DNA-dependent protein kinase and poly(ADP-ribose) polymerase-1. , 2003, Cancer research.

[32]  N. Curtin,et al.  Effects of novel inhibitors of poly(ADP-ribose) polymerase-1 and the DNA-dependent protein kinase on enzyme activities and DNA repair , 2004, Oncogene.

[33]  J. Yokota,et al.  Molecular processes of chromosome 9p21 deletions causing inactivation of the p16 tumor suppressor gene in human cancer: deduction from structural analysis of breakpoints for deletions. , 2006, DNA repair.

[34]  B. Bertocci,et al.  Nonoverlapping functions of DNA polymerases mu, lambda, and terminal deoxynucleotidyltransferase during immunoglobulin V(D)J recombination in vivo. , 2006, Immunity.

[35]  Yunmei Ma,et al.  Mechanism and regulation of human non-homologous DNA end-joining , 2003, Nature Reviews Molecular Cell Biology.

[36]  D. Roth,et al.  Double-strand break repair in Ku86- and XRCC4-deficient cells. , 1998, Nucleic acids research.